Advanced search
Publication Cover
Renal Failure Volume 40, 2018 - Issue 1
Submit an article Journal homepage
1,624
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis

Lan ChenDepartment of Nephrology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Jin-Xuan HeDepartment of Nephrology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Ying-Ying ChenDepartment of Nephrology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Yi-Sheng LingDepartment of Nephrology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Chun-Hua LinDepartment of Nephrology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, ChinaView further author information
&
Tian-Jun GuanDepartment of Nephrology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, ChinaCorrespondence[email protected]
View further author information
Pages 15-21 | Received 06 Jun 2017, Accepted 14 Dec 2017, Published online: 02 Jan 2018

References

  • Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–822.
  • Denda M, Finch J, Slatopolsky E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis. 1996;28:596–602.
  • Slatopolsky E, Brown AJ, Dusso A. Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl. 1999;73:S14–S19.
  • Sim JJ, Bhandari SK, Smith N, et al. Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med. 2013;126:311–318.
  • Li J, Molnar MZ, Zaritsky JJ, et al. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013;28:1516–1525.
  • Lertdumrongluk P, Rhee CM, Park J, et al. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Ren Nutr. 2013;23:411–421.
  • Kalantar-Zadeh K, Ikizler TA. Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr. 2013;23:157–163.
  • Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013;33:180–190.
  • Cupisti A, Benini O, Ferretti V, et al. Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives. J Ren Nutr. 2012;22:533–540.
  • Streja E, Lau WL, Goldstein L, et al. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl. 2013;3:462–468.
  • Martin DR, Ritter CS, Slatopolsky E, et al. Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab. 2005;289:E729–E734.
  • Ritter CS, Martin DR, Lu Y, et al. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res. 2002;17:2206–2213.
  • Lopez-Hilker S, Dusso AS, Rapp NS, et al. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol Renal Fluid Electrolyte Physiol. 1990;259:F432–F437.
  • Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95:560–567.
  • Chen NX, O’Neill KD, Duan D, et al. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62:1724–1731.
  • Narang R, Ridout D, Nonis C, et al. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol. 1997;60:73–79.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;S1–S130.
  • Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;52: 519–530.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–S266.
  • Corbetta S, Mantovani G, Lania A, et al. Calcium-sensing receptor expression and signaling in human parathyroid adenomas and primary hyperplasia. Clin Endocrinol. 2000;52:339–348.
  • Farnebo F, Enberg U, Grimelius L, et al. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab. 1997;82:3481–3486.
  • Gogusev J, Duchambon P, Hory B, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 1997;51:328–336.
  • Kifor O, Moore FD, Wang P, et al. Reduced immunostaining for the extracellular Ca2-sensing receptor in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81:1598–1606.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.